# New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer

> **NCT06097936** · — · UNKNOWN · sponsor: **Regina Elena Cancer Institute** · enrollment: 20 (estimated)

## Conditions studied

- PREDICTIVE BIOMARKERS
- Evaluation of HPV-specific E5 Transcript Expression in a Cohort of Patients With HPV-associated OPC
- HPV 16 Positive Oropharyngeal Tumors (OPC)

## Interventions

- **DIAGNOSTIC_TEST:** HPV-ASSOCIATED OROPHARYNGEAL CANCER

## Key facts

- **NCT ID:** NCT06097936
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-15
- **Primary completion:** 2022-12-13
- **Final completion:** 2024-04-01
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-10-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06097936

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06097936, "New Prognostic and Predictive Biomarkers for HPV-associated Oropharyngeal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06097936. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*